sun 1165 Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now

Chemistry

  • SMILES: Cc1cccc(C)c1NC(=O)CC12CCCN1CCC2
  • InChIKey: BCQTVJKBTWGHCX-UHFFFAOYSA-N
  • Mol. Mass: 272.39
  • ALogP: 3.26
  • ChEMBL Molecule:
    pilsicainide  
More Chemistry

Pharmacology

Alternative names

1h-pyrrolizine-7a(5h)-acetamide, n-(2,6-dimethylphenyl)tetrahydro-, hydrochloride (1:1) | 1h-pyrrolizine-7a(5h)-acetamide, n-(2,6-dimethylphenyl)tetrahydro-, hydrochloride hemihydrate | n-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride | pilsicainide | pilsicainide hcl | pilsicainide hydrochloride | pilsicainide hydrochloride hemihydrate | pilsicainide hydrochloride hydrate | pilzicainide | sun 1165 | sun-1165 | tetrahydro-1h-pyrrolizine-7a(5h)-aceto-2',6'-xylidide

Organizations (1)

Research & Development (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Overview

  • Highest Phase: N/A
  • # of Trials: 1
  • # of Trial Organizations: 1

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue